Sfoglia per Rivista
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice
2019-01-01 Fava, Carmen; Rege-Cambrin, Giovanna; Dogliotti, Irene; Cerrano, Marco; Berchialla, Paola; Dragani, Matteo; Rosti, Gianantonio; Castagnetti, Fausto; Gugliotta, Gabriele; Martino, Bruno; Gambacorti-Passerini, Carlo; Abruzzese, Elisabetta; Elena, Chiara; Pregno, Patrizia; Gozzini, Antonella; Capodanno, Isabella; Bergamaschi, Micaela; Crugnola, Monica; Bocchia, Monica; Galimberti, Sara; Rapezzi, Davide; Iurlo, Alessandra; Cattaneo, Daniele; Latagliata, Roberto; Breccia, Massimo; Cedrone, Michele; Santoro, Marco; Annunziata, Mario; Levato, Luciano; Stagno, Fabio; Cavazzini, Francesco; Sgherza, Nicola; Giai, Valentina; Luciano, Luigia; Russo, Sabina; Musto, Pellegrino; Caocci, Giovanni; Sorà, Federica; Iuliano, Francesco; Lunghi, Francesca; Specchia, Giorgina; Pane, Fabrizio; Ferrero, Dario; Baccarani, Michele; Saglio, Giuseppe
Occourrence of pleural effusions during dasatinib treatment in elderly chronic myelogenous leukemia patients.
2009-01-01 Latagliata R.; Breccia M.; Stagno F.; Luciano L.; Gozzini A.; Annunziata M.; De Matteis S.; Albano F.; Ulisciani S.; Pregno P.; Pacilli M.; Abruzzese E.; Martino B.; Tiribelli M.; Avanzini P.; Pacilli L.; Vigneri P.; Fabbricini R; Russo Rossi A.; Sica S.; Vitolo U.; Montefusco E.; Fava C.; Ferrara F.; Santini V.; Pane F.; Di Raimondo F.; Alimena G.
Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: A pooled analysis of two phase i/ii studies
2019-01-01 Bringhen S.; Mina R.; Petrucci M.T.; Gaidano G.; Ballanti S.; Musto P.; Offidani M.; Spada S.; Benevolo G.; Ponticelli E.; Galieni P.; Cavo M.; Di Toritto T.C.; Di Raimondo F.; Montefusco V.; Palumbo A.; Boccadoro M.; Larocca A.
Oral chemotherapy: an innovative choice
2015-01-01 Bergui, L.; Scaldaferri, M.; Sciorsci, E.; Valinotti, G.; Ghiggia, A.; Cavallo, F.; Ferrero, S.; Ghione, P.; Castelli, L.; Torta, R.
Oral Chemotherapy: an innovative choice
2013-01-01 Bergui L.; Ghione P.; Ladetto M.; Castelli L.; Giaretti M.; Scaldaferri M; Sciorsci E; Cattel F.
Oral melphalan at diagnosis hampers adeguate collection of peripheral blood progenitor cells in multiple myeloma.
2002-01-01 Boccadoro M; Palumbo A; Bringhen S; Merletti F; Ciccone G; Richiardi L; Rus C; Bertola A; Giaccone L; Omedè P; Musto P; Pileri A
Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors.
2013-01-01 Russo Rossi A;Breccia M;Abruzzese E;Castagnetti F;Luciano L;Gozzini A;Annunziata M;Martino B;Stagno F;Cavazzini F;Tiribelli M;Visani G;Pregno P;Musto P;Fava C;Sgherza N;Albano F;Rosti G;Alimena G;Specchia G
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: A report from the Italian Pediatric Group
2007-01-01 Locatelli, Franco; Zecca, Marco; Pession, Andrea; Morreale, Giuseppe; Longoni, Daniela; Di Bartolomeo, Paolo; Porta, Fulvio; Fagioli, Franca; Nobili, Bruno; Bernardo, Maria Ester; Messina, Chiara
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs
2020-01-01 Montefusco V.; Gay F.; Spada S.; de Paoli L.; Raimondo F.D.; Ribolla R.; Musolino C.; Patriarca F.; Musto P.; Galieni P.; Ballanti S.; Nozzoli C.; Cascavilla N.; Ben-Yehuda D.; Nagler A.; Hajek R.; Offidani M.; Liberati A.M.; Sonneveld P.; Cavo M.; Corradini P.; Boccadoro M.
Outcome of patients with chronic phase CML treated with dasatinib or nilotinib after failure of second prior TKIs.
2011-01-01 A. Russo Rossi; F. Castagnetti; M. Breccia; L. Luciano; A. Gozzini; M. Annunziata; B. Martino; F. Stagno; F. Cavazzini; M. Tiribelli; G. Visani; P. Pregno; P. Musto; C. Fava; P. Avanzini; D. Turri; F. Porretto; E. Abruzzese; N. Sgherza; F. Albano; G. Specchia.
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: A study from the acute leukemia working party of the european society for blood and marrow transplantation
2018-01-01 Salvatore D.; Labopin M.; Ruggeri A.; Battipaglia G.; Ghavamzadeh A.; Ciceri F.; Blaise D.; Arcese W.; Socie G.; Bourhis J.H.; Van Lint M.T.; Bruno B.; Huynh A.; Santarone S.; Deconinck E.; Mohty M.; Nagler A.
Overexpression of the p65 subunit of NF-KB and IKB mediated nuclear sequestration of p53 as common events in Philadelphia positive and negative myeloproliferative disorders
2005-01-01 Morotti A; Arruga F; Messa F; Defilippi I; Pautasso M; Baraban D; Giugliano E; Scaravaglio P; Rege-Cambrin G; Taulli R; Gottardi E; Cilloni D; Saglio G
THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA
2012-01-01 Brusa D; Serra S; Bianco M; Coscia M; Rossi D; Gaidano G; Fedele G; Deaglio S
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia.
2013-01-01 Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S.
Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
2002-01-01 F. MORABITO; M. MANGIOLA; C. STELITANO; S. DEAGLIO; V. CALLEA; F. MALAVASI
Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications.
1996-01-01 AGLIETTA M ;DE VINCENTIIS A ;LANATA L ;LANZA F ;LEMOLI RM ;MENICHELLA G ;TAFURI A ;ZANON P ;TURA S
Persisting molecular remission ten years after donor lymphocyte infusion for hematologic relapse in chronic myeloid leukemia
2001-01-01 Mattei, D; Saglio, G; Gottardi, E; Gallamini, A; Mordini, N; Bacigalupo, A
Personalized medicine in lymphoma: Is it worthwhile? The mantle cell lymphoma experience
2015-01-01 Dreyling, Martin; Ferrero, Simone
PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS
2014-01-01 Fava C; Cusato J; Ariaudo A; D'Avolio A; De Francia S; Giugliano E; Rege-Cambrin G; Saglio G
PHASE 3 ALCANZA STUDY OF BRENTUXIMAB VEDOTIN (BV) OR PHYSICIAN'S CHOICE (PC) OF METHOTREXATE (MTX) OR BEXAROTENE (BEX) IN CD30-POSITIVE CUTANEOUS T-CELL LYMPHOMA (CTCL): NUMBER NEEDED TO TREAT ANALYSIS
2017-01-01 Zagadailov, E; Prince, HM; Whittaker, S; Horwitz, S; Duvic, M; Kim, Y; Dummer, R; Scarisbrick, J; Quaglino, P; Zinzani, PL; Wolter, P; Geskin, L; Feliciano, J; Wang, Y; Palanca-Wessels, MC; Gautam, A; Zhu, Y; Lin, HM; Liu, Y; Little, M; Dalal, MR
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice | 2019 | Fava, Carmen; Rege-Cambrin, Giovanna; Dogliotti, Irene; Cerrano, Marco; Berchialla, Paola; Dragani, Matteo; Rosti, Gianantonio; Castagnetti, Fausto; Gugliotta, Gabriele; Martino, Bruno; Gambacorti-Passerini, Carlo; Abruzzese, Elisabetta; Elena, Chiara; Pregno, Patrizia; Gozzini, Antonella; Capodanno, Isabella; Bergamaschi, Micaela; Crugnola, Monica; Bocchia, Monica; Galimberti, Sara; Rapezzi, Davide; Iurlo, Alessandra; Cattaneo, Daniele; Latagliata, Roberto; Breccia, Massimo; Cedrone, Michele; Santoro, Marco; Annunziata, Mario; Levato, Luciano; Stagno, Fabio; Cavazzini, Francesco; Sgherza, Nicola; Giai, Valentina; Luciano, Luigia; Russo, Sabina; Musto, Pellegrino; Caocci, Giovanni; Sorà, Federica; Iuliano, Francesco; Lunghi, Francesca; Specchia, Giorgina; Pane, Fabrizio; Ferrero, Dario; Baccarani, Michele; Saglio, Giuseppe | |
| Occourrence of pleural effusions during dasatinib treatment in elderly chronic myelogenous leukemia patients. | 2009 | Latagliata R.; Breccia M.; Stagno F.; Luciano L.; Gozzini A.; Annunziata M.; De Matteis S.; Albano F.; Ulisciani S.; Pregno P.; Pacilli M.; Abruzzese E.; Martino B.; Tiribelli M.; Avanzini P.; Pacilli L.; Vigneri P.; Fabbricini R; Russo Rossi A.; Sica S.; Vitolo U.; Montefusco E.; Fava C.; Ferrara F.; Santini V.; Pane F.; Di Raimondo F.; Alimena G. | |
| Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: A pooled analysis of two phase i/ii studies | 2019 | Bringhen S.; Mina R.; Petrucci M.T.; Gaidano G.; Ballanti S.; Musto P.; Offidani M.; Spada S.; Benevolo G.; Ponticelli E.; Galieni P.; Cavo M.; Di Toritto T.C.; Di Raimondo F.; Montefusco V.; Palumbo A.; Boccadoro M.; Larocca A. | |
| Oral chemotherapy: an innovative choice | 2015 | Bergui, L.; Scaldaferri, M.; Sciorsci, E.; Valinotti, G.; Ghiggia, A.; Cavallo, F.; Ferrero, S.; Ghione, P.; Castelli, L.; Torta, R. | |
| Oral Chemotherapy: an innovative choice | 2013 | Bergui L.; Ghione P.; Ladetto M.; Castelli L.; Giaretti M.; Scaldaferri M; Sciorsci E; Cattel F. | |
| Oral melphalan at diagnosis hampers adeguate collection of peripheral blood progenitor cells in multiple myeloma. | 2002 | Boccadoro M; Palumbo A; Bringhen S; Merletti F; Ciccone G; Richiardi L; Rus C; Bertola A; Giaccone L; Omedè P; Musto P; Pileri A | |
| Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors. | 2013 | Russo Rossi A;Breccia M;Abruzzese E;Castagnetti F;Luciano L;Gozzini A;Annunziata M;Martino B;Stagno F;Cavazzini F;Tiribelli M;Visani G;Pregno P;Musto P;Fava C;Sgherza N;Albano F;Rosti G;Alimena G;Specchia G | |
| The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: A report from the Italian Pediatric Group | 2007 | Locatelli, Franco; Zecca, Marco; Pession, Andrea; Morreale, Giuseppe; Longoni, Daniela; Di Bartolomeo, Paolo; Porta, Fulvio; Fagioli, Franca; Nobili, Bruno; Bernardo, Maria Ester; Messina, Chiara | |
| Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs | 2020 | Montefusco V.; Gay F.; Spada S.; de Paoli L.; Raimondo F.D.; Ribolla R.; Musolino C.; Patriarca F.; Musto P.; Galieni P.; Ballanti S.; Nozzoli C.; Cascavilla N.; Ben-Yehuda D.; Nagler A.; Hajek R.; Offidani M.; Liberati A.M.; Sonneveld P.; Cavo M.; Corradini P.; Boccadoro M. | |
| Outcome of patients with chronic phase CML treated with dasatinib or nilotinib after failure of second prior TKIs. | 2011 | A. Russo Rossi; F. Castagnetti; M. Breccia; L. Luciano; A. Gozzini; M. Annunziata; B. Martino; F. Stagno; F. Cavazzini; M. Tiribelli; G. Visani; P. Pregno; P. Musto; C. Fava; P. Avanzini; D. Turri; F. Porretto; E. Abruzzese; N. Sgherza; F. Albano; G. Specchia. | |
| Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: A study from the acute leukemia working party of the european society for blood and marrow transplantation | 2018 | Salvatore D.; Labopin M.; Ruggeri A.; Battipaglia G.; Ghavamzadeh A.; Ciceri F.; Blaise D.; Arcese W.; Socie G.; Bourhis J.H.; Van Lint M.T.; Bruno B.; Huynh A.; Santarone S.; Deconinck E.; Mohty M.; Nagler A. | |
| Overexpression of the p65 subunit of NF-KB and IKB mediated nuclear sequestration of p53 as common events in Philadelphia positive and negative myeloproliferative disorders | 2005 | Morotti A; Arruga F; Messa F; Defilippi I; Pautasso M; Baraban D; Giugliano E; Scaravaglio P; Rege-Cambrin G; Taulli R; Gottardi E; Cilloni D; Saglio G | |
| THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2012 | Brusa D; Serra S; Bianco M; Coscia M; Rossi D; Gaidano G; Fedele G; Deaglio S | |
| The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia. | 2013 | Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S. | |
| Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. | 2002 | F. MORABITO; M. MANGIOLA; C. STELITANO; S. DEAGLIO; V. CALLEA; F. MALAVASI | |
| Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications. | 1996 | AGLIETTA M ;DE VINCENTIIS A ;LANATA L ;LANZA F ;LEMOLI RM ;MENICHELLA G ;TAFURI A ;ZANON P ;TURA S | |
| Persisting molecular remission ten years after donor lymphocyte infusion for hematologic relapse in chronic myeloid leukemia | 2001 | Mattei, D; Saglio, G; Gottardi, E; Gallamini, A; Mordini, N; Bacigalupo, A | |
| Personalized medicine in lymphoma: Is it worthwhile? The mantle cell lymphoma experience | 2015 | Dreyling, Martin; Ferrero, Simone | |
| PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS | 2014 | Fava C; Cusato J; Ariaudo A; D'Avolio A; De Francia S; Giugliano E; Rege-Cambrin G; Saglio G | |
| PHASE 3 ALCANZA STUDY OF BRENTUXIMAB VEDOTIN (BV) OR PHYSICIAN'S CHOICE (PC) OF METHOTREXATE (MTX) OR BEXAROTENE (BEX) IN CD30-POSITIVE CUTANEOUS T-CELL LYMPHOMA (CTCL): NUMBER NEEDED TO TREAT ANALYSIS | 2017 | Zagadailov, E; Prince, HM; Whittaker, S; Horwitz, S; Duvic, M; Kim, Y; Dummer, R; Scarisbrick, J; Quaglino, P; Zinzani, PL; Wolter, P; Geskin, L; Feliciano, J; Wang, Y; Palanca-Wessels, MC; Gautam, A; Zhu, Y; Lin, HM; Liu, Y; Little, M; Dalal, MR |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile